NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

14 hedge funds and large institutions have $2.27M invested in NeuBase Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$435K
2
+$140K
3
+$88K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$66.1K
5
Morgan Stanley
Morgan Stanley
New York
+$21K

Top Sellers

1
-$97.6K
2
-$87K
3
-$47K
4
First Manhattan
First Manhattan
New York
-$13K
5
Deutsche Bank
Deutsche Bank
Germany
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.07M
2
$529K
3
$214K
4
$140K
5
$89K
6
$88K
7
$47K
8
$24K
9
$21K
10
$15K
11
$11K
12
$11K
13
$9K
14
$3K
15
–
16
–